FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103299414> ?p ?o ?g. }

• W2103299414 endingPage "1099" @default.
• W2103299414 startingPage "1091" @default.
• W2103299414 abstract "Summary. Background and objectives: Thrombin‐activatable fibrinolysis inhibitor (TAFI) is a zymogen that can be activated by proteolytic cleavage into the active enzyme TAFIa. Hydrolysis of the C‐terminal lysines on fibrin by TAFIa results in a down‐regulation of fibrinolysis. Recent studies demonstrated that the zymogen also exerts an intrinsic enzymatic activity. Our objective was to identify and characterize zymogen‐stimulatory nanobodies.Methods and results:The screening of 24 nanobodies against TAFI revealed that two nanobodies (i.e. Vhh‐TAFI‐a51 and Vhh‐TAFI‐i103) were able to stimulate the zymogen activity 10‐ to 21‐fold compared with the baseline zymogen activity of TAFI. The increase in catalytic efficiency can be attributed mainly to an increased catalytic rate, as no change in the KM‐value was observed. The stability, the susceptibility towards PTCI and GEMSA and the kinetics of the stimulated zymogen activity differ significantly from those of TAFIa activity. Epitope mapping revealed that both Asp75 and Thr301 are major determinants in the binding of these nanobodies to TAFI. Localization of the epitope strongly suggests that this instability is as a result of a disruption of the stabilizing interactions between the activation peptide and the dynamic flap region (residues 296–350).In TAFI‐depleted plasma reconstituted with a non‐activatable variant of TAFI (TAFI‐R92A), clot lysis could be prolonged by nanobody‐induced stimulation of its zymogen activity as well as by increasing its concentration.Conclusions:Increasing the zymogen activity of TAFI results in an antifibrinolytic effect. Summary. Background and objectives: Thrombin‐activatable fibrinolysis inhibitor (TAFI) is a zymogen that can be activated by proteolytic cleavage into the active enzyme TAFIa. Hydrolysis of the C‐terminal lysines on fibrin by TAFIa results in a down‐regulation of fibrinolysis. Recent studies demonstrated that the zymogen also exerts an intrinsic enzymatic activity. Our objective was to identify and characterize zymogen‐stimulatory nanobodies. The screening of 24 nanobodies against TAFI revealed that two nanobodies (i.e. Vhh‐TAFI‐a51 and Vhh‐TAFI‐i103) were able to stimulate the zymogen activity 10‐ to 21‐fold compared with the baseline zymogen activity of TAFI. The increase in catalytic efficiency can be attributed mainly to an increased catalytic rate, as no change in the KM‐value was observed. The stability, the susceptibility towards PTCI and GEMSA and the kinetics of the stimulated zymogen activity differ significantly from those of TAFIa activity. Epitope mapping revealed that both Asp75 and Thr301 are major determinants in the binding of these nanobodies to TAFI. Localization of the epitope strongly suggests that this instability is as a result of a disruption of the stabilizing interactions between the activation peptide and the dynamic flap region (residues 296–350). In TAFI‐depleted plasma reconstituted with a non‐activatable variant of TAFI (TAFI‐R92A), clot lysis could be prolonged by nanobody‐induced stimulation of its zymogen activity as well as by increasing its concentration. Increasing the zymogen activity of TAFI results in an antifibrinolytic effect." @default.
• W2103299414 created "2016-06-24" @default.
• W2103299414 creator A5002675935 @default.
• W2103299414 creator A5005894474 @default.
• W2103299414 creator A5043590871 @default.
• W2103299414 creator A5074388972 @default.
• W2103299414 creator A5082317019 @default.
• W2103299414 creator A5090880326 @default.
• W2103299414 date "2012-06-01" @default.
• W2103299414 modified "2023-09-30" @default.
• W2103299414 title "Increased zymogen activity of thrombin‐activatable fibrinolysis inhibitor prolongs clot lysis" @default.
• W2103299414 cites W1521574535 @default.
• W2103299414 cites W1537505224 @default.
• W2103299414 cites W1758955113 @default.
• W2103299414 cites W1971308798 @default.
• W2103299414 cites W1977497608 @default.
• W2103299414 cites W1979961711 @default.
• W2103299414 cites W1980194875 @default.
• W2103299414 cites W1994639179 @default.
• W2103299414 cites W2005759587 @default.
• W2103299414 cites W2019102633 @default.
• W2103299414 cites W2023626030 @default.
• W2103299414 cites W2029533146 @default.
• W2103299414 cites W2053174541 @default.
• W2103299414 cites W2062617301 @default.
• W2103299414 cites W2066822578 @default.
• W2103299414 cites W2069436323 @default.
• W2103299414 cites W2079337300 @default.
• W2103299414 cites W2087840851 @default.
• W2103299414 cites W2095083583 @default.
• W2103299414 cites W2116943300 @default.
• W2103299414 cites W2140576495 @default.
• W2103299414 cites W2152988106 @default.
• W2103299414 cites W55986542 @default.
• W2103299414 doi "https://doi.org/10.1111/j.1538-7836.2012.04738.x" @default.
• W2103299414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22498006" @default.
• W2103299414 hasPublicationYear "2012" @default.
• W2103299414 type Work @default.
• W2103299414 sameAs 2103299414 @default.
• W2103299414 citedByCount "8" @default.
• W2103299414 countsByYear W21032994142013 @default.
• W2103299414 countsByYear W21032994142014 @default.
• W2103299414 countsByYear W21032994142015 @default.
• W2103299414 countsByYear W21032994142016 @default.
• W2103299414 countsByYear W21032994142020 @default.
• W2103299414 crossrefType "journal-article" @default.
• W2103299414 hasAuthorship W2103299414A5002675935 @default.
• W2103299414 hasAuthorship W2103299414A5005894474 @default.
• W2103299414 hasAuthorship W2103299414A5043590871 @default.
• W2103299414 hasAuthorship W2103299414A5074388972 @default.
• W2103299414 hasAuthorship W2103299414A5082317019 @default.
• W2103299414 hasAuthorship W2103299414A5090880326 @default.
• W2103299414 hasBestOaLocation W21032994141 @default.
• W2103299414 hasConcept C126322002 @default.
• W2103299414 hasConcept C141071460 @default.
• W2103299414 hasConcept C147483822 @default.
• W2103299414 hasConcept C181199279 @default.
• W2103299414 hasConcept C185592680 @default.
• W2103299414 hasConcept C195616568 @default.
• W2103299414 hasConcept C201267052 @default.
• W2103299414 hasConcept C203014093 @default.
• W2103299414 hasConcept C2776825266 @default.
• W2103299414 hasConcept C2777292125 @default.
• W2103299414 hasConcept C2778775115 @default.
• W2103299414 hasConcept C2779637338 @default.
• W2103299414 hasConcept C2781436528 @default.
• W2103299414 hasConcept C2991743468 @default.
• W2103299414 hasConcept C54173615 @default.
• W2103299414 hasConcept C55493867 @default.
• W2103299414 hasConcept C57409179 @default.
• W2103299414 hasConcept C71924100 @default.
• W2103299414 hasConcept C89560881 @default.
• W2103299414 hasConcept C98274493 @default.
• W2103299414 hasConceptScore W2103299414C126322002 @default.
• W2103299414 hasConceptScore W2103299414C141071460 @default.
• W2103299414 hasConceptScore W2103299414C147483822 @default.
• W2103299414 hasConceptScore W2103299414C181199279 @default.
• W2103299414 hasConceptScore W2103299414C185592680 @default.
• W2103299414 hasConceptScore W2103299414C195616568 @default.
• W2103299414 hasConceptScore W2103299414C201267052 @default.
• W2103299414 hasConceptScore W2103299414C203014093 @default.
• W2103299414 hasConceptScore W2103299414C2776825266 @default.
• W2103299414 hasConceptScore W2103299414C2777292125 @default.
• W2103299414 hasConceptScore W2103299414C2778775115 @default.
• W2103299414 hasConceptScore W2103299414C2779637338 @default.
• W2103299414 hasConceptScore W2103299414C2781436528 @default.
• W2103299414 hasConceptScore W2103299414C2991743468 @default.
• W2103299414 hasConceptScore W2103299414C54173615 @default.
• W2103299414 hasConceptScore W2103299414C55493867 @default.
• W2103299414 hasConceptScore W2103299414C57409179 @default.
• W2103299414 hasConceptScore W2103299414C71924100 @default.
• W2103299414 hasConceptScore W2103299414C89560881 @default.
• W2103299414 hasConceptScore W2103299414C98274493 @default.
• W2103299414 hasIssue "6" @default.
• W2103299414 hasLocation W21032994141 @default.
• W2103299414 hasLocation W21032994142 @default.
• W2103299414 hasOpenAccess W2103299414 @default.
• W2103299414 hasPrimaryLocation W21032994141 @default.

• next